Wealth Enhancement Advisory Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
115,750
+10,741
| +10% | +$1.12M | 0.02% | 571 |
|
|
2025
Q1 | $10.6M | Buy |
105,009
+24,856
| +31% | +$2.51M | 0.02% | 561 |
|
|
2024
Q4 | $7.16M | Sell |
80,153
-78,385
| -49% | -$7M | 0.01% | 671 |
|
|
2024
Q3 | $13.3M | Buy |
158,538
+87,470
| +123% | +$7.33M | 0.03% | 446 |
|
|
2024
Q2 | $5.47M | Buy |
71,068
+5,044
| +8% | +$388K | 0.01% | 661 |
|
|
2024
Q1 | $4.52M | Buy |
66,024
+6,485
| +11% | +$444K | 0.01% | 691 |
|
|
2023
Q4 | $3.44M | Sell |
59,539
-1,929
| -3% | -$112K | 0.01% | 714 |
|
|
2023
Q3 | $3.25M | Buy |
+61,468
| New | +$3.25M | 0.01% | 687 |
|
|
2023
Q2 | – | Sell |
-7,328
| Closed | -$367K | – | 518 |
|
|
2023
Q1 | $367K | Buy |
+7,328
| New | +$367K | ﹤0.01% | 419 |
|
|
2019
Q2 | – | Sell |
-27,867
| Closed | -$1M | – | 206 |
|
|
2019
Q1 | $1M | Buy |
+27,867
| New | +$1M | 0.06% | 141 |
|
|
2017
Q1 | – | Sell |
-96,166
| Closed | -$2.08M | – | 140 |
|
|
2016
Q4 | $2.08M | Buy |
+96,166
| New | +$2.08M | 0.25% | 52 |
|